The ultimately fatal outcome of autoimmune diabetes in the widely used and clinically relevant murine NOD model of human T1D depends on progressive and relentless destruction of insulin-producing beta cells in pancreatic islets and is inevitable unless insulin-replacement therapy is instituted. Here, INS is linked to type 1 diabetes mellitus.